BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2181041)

  • 1. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
    N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
    Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin for the treatment of leprosy.
    Ji B; Grosset J
    Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term trial of clofazimine in previously untreated lepromatous leprosy.
    Jamet P; Traore I; Husser JA; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):542-8. PubMed ID: 1299709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.
    Pardillo FE; Burgos J; Fajardo TT; Dela Crux E; Abalos RM; Paredes RM; Andaya CE; Gelber RH
    Lepr Rev; 2009 Jun; 80(2):205-9. PubMed ID: 19743625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; LĂ©oture A; Grosset JH; Sansarricq H
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
    Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of fusidic acid cream in leprosy.
    Mahajan PM; Jadhav VH; Jogaikar DG; Mehta JM
    Indian J Lepr; 2000; 72(4):451-5. PubMed ID: 11212479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ofloxacin against Mycobacterium leprae in the mouse.
    Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacin in leprosy.
    Bharti R
    Indian J Lepr; 1994; 66(4):443-8. PubMed ID: 7714353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.